Review paper
Molecular pathway activation – New type of biomarkers for tumor morphology and personalized selection of target drugs
Abstract
Anticancer target drugs (ATDs) specifically bind and inhibit molecular targets that play important roles in cancer development and progression, being deeply implicated in intracellular signaling pathways. To date, hundreds of different ATDs were approved for clinical use in the different countries. Compared to previous chemotherapy treatments, ATDs often demonstrate reduced side effects and increased efficiency, but also have higher costs....
Paper Details
Title
Molecular pathway activation – New type of biomarkers for tumor morphology and personalized selection of target drugs
Published Date
Dec 1, 2018
Journal
Volume
53
Pages
110 - 124
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History